Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

261

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

November 30, 2026

Conditions

Essential Arterial Hypertension

Interventions

DRUG

Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg

1 tablet a day

DRUG

Olmesartan medoxomil 20mg + Chlortalidone 25mg

1 tablet a day

DRUG

Olmesartan 20mg + hydrochlorothiazide 12,5mg

1 tablet a day